Pharmacological Treatments for Alzheimer’s Disease in Primary Care / Management of Cognitive Symptoms (DTB / Nursing Times)

Summary

A Drug and Therapeutics Bulletin (DTB) article reviews the evidence concerning drugs prescribed for cognitive symptoms in Alzheimer’s Disease and discusses some issues in their prescription. Donepezil, galantamine and rivastigmine are licensed for mild to moderate Alzheimer’s Disease in the UK. Memantine is licensed for use in moderate to severe Alzheimer’s Disease. The National Institute for Health and Care Excellence (NICE) recommends that treatment should be initiated by specialists, while often responsibility for continued prescription of these drugs is handled by primary care in the UK.

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).

Reference

Prescribing drugs for Alzheimer’s disease in primary care: managing cognitive symptoms. Drug and Therapeutics Bulletin, 2014, Vol.52(6), pp.69-72. (Click here to view the PubMed abstract).

Possibly of interest, is a Nursing Times article providing practice-based guidance which aims to help nurses ensure patients get the correct anti-dementia medication. Memory clinic services, including prescribing, are often led by nurses.

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).

Reference

Prentice, A. [and] Wright, D. (2014). A guide to prescribing anti-dementia medication. Nursing Times, [May 30th 2014] June 4th 2014, 110(22), 16-17.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Management of Condition, Models of Dementia Care, NICE Guidelines, Pharmacological Treatments, Practical Advice, Quick Insights, UK and tagged , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.